Similarity Score |
Similarity Level |
Drug ID |
Developmental Stage |
0.912 |
High Similarity |
NPD943 |
Approved |
0.8968 |
High Similarity |
NPD1240 |
Approved |
0.8837 |
High Similarity |
NPD1510 |
Phase 2 |
0.8828 |
High Similarity |
NPD1607 |
Approved |
0.8692 |
High Similarity |
NPD1509 |
Clinical (unspecified phase) |
0.8636 |
High Similarity |
NPD1549 |
Phase 2 |
0.8561 |
High Similarity |
NPD1550 |
Clinical (unspecified phase) |
0.8561 |
High Similarity |
NPD1552 |
Clinical (unspecified phase) |
0.8409 |
Intermediate Similarity |
NPD651 |
Clinical (unspecified phase) |
0.8291 |
Intermediate Similarity |
NPD74 |
Approved |
0.8291 |
Intermediate Similarity |
NPD9266 |
Approved |
0.8268 |
Intermediate Similarity |
NPD1470 |
Approved |
0.8268 |
Intermediate Similarity |
NPD1164 |
Approved |
0.824 |
Intermediate Similarity |
NPD1201 |
Approved |
0.8205 |
Intermediate Similarity |
NPD9267 |
Approved |
0.8205 |
Intermediate Similarity |
NPD9263 |
Approved |
0.8205 |
Intermediate Similarity |
NPD9264 |
Approved |
0.8205 |
Intermediate Similarity |
NPD9265 |
Clinical (unspecified phase) |
0.8188 |
Intermediate Similarity |
NPD1511 |
Approved |
0.8129 |
Intermediate Similarity |
NPD7410 |
Clinical (unspecified phase) |
0.8129 |
Intermediate Similarity |
NPD4378 |
Clinical (unspecified phase) |
0.8071 |
Intermediate Similarity |
NPD1512 |
Approved |
0.8058 |
Intermediate Similarity |
NPD7390 |
Discontinued |
0.8049 |
Intermediate Similarity |
NPD405 |
Clinical (unspecified phase) |
0.8049 |
Intermediate Similarity |
NPD9493 |
Approved |
0.7984 |
Intermediate Similarity |
NPD1203 |
Approved |
0.7972 |
Intermediate Similarity |
NPD4380 |
Phase 2 |
0.7956 |
Intermediate Similarity |
NPD970 |
Clinical (unspecified phase) |
0.7941 |
Intermediate Similarity |
NPD2796 |
Approved |
0.7941 |
Intermediate Similarity |
NPD1551 |
Phase 2 |
0.7929 |
Intermediate Similarity |
NPD6799 |
Approved |
0.7891 |
Intermediate Similarity |
NPD9269 |
Phase 2 |
0.7886 |
Intermediate Similarity |
NPD9281 |
Approved |
0.7863 |
Intermediate Similarity |
NPD9261 |
Approved |
0.7857 |
Intermediate Similarity |
NPD9268 |
Approved |
0.7842 |
Intermediate Similarity |
NPD3750 |
Approved |
0.781 |
Intermediate Similarity |
NPD5406 |
Approved |
0.781 |
Intermediate Similarity |
NPD5408 |
Approved |
0.781 |
Intermediate Similarity |
NPD5405 |
Approved |
0.781 |
Intermediate Similarity |
NPD5404 |
Approved |
0.7793 |
Intermediate Similarity |
NPD7411 |
Suspended |
0.7778 |
Intermediate Similarity |
NPD9545 |
Approved |
0.7778 |
Intermediate Similarity |
NPD940 |
Approved |
0.7778 |
Intermediate Similarity |
NPD846 |
Approved |
0.774 |
Intermediate Similarity |
NPD1934 |
Approved |
0.7717 |
Intermediate Similarity |
NPD4196 |
Clinical (unspecified phase) |
0.7714 |
Intermediate Similarity |
NPD1878 |
Clinical (unspecified phase) |
0.7703 |
Intermediate Similarity |
NPD3882 |
Suspended |
0.7692 |
Intermediate Similarity |
NPD1242 |
Phase 1 |
0.7687 |
Intermediate Similarity |
NPD2393 |
Clinical (unspecified phase) |
0.7687 |
Intermediate Similarity |
NPD2801 |
Approved |
0.7681 |
Intermediate Similarity |
NPD2935 |
Discontinued |
0.7651 |
Intermediate Similarity |
NPD7075 |
Discontinued |
0.7651 |
Intermediate Similarity |
NPD4381 |
Clinical (unspecified phase) |
0.7651 |
Intermediate Similarity |
NPD3749 |
Approved |
0.7635 |
Intermediate Similarity |
NPD8443 |
Clinical (unspecified phase) |
0.7626 |
Intermediate Similarity |
NPD2344 |
Approved |
0.7615 |
Intermediate Similarity |
NPD9717 |
Approved |
0.7603 |
Intermediate Similarity |
NPD6599 |
Discontinued |
0.7591 |
Intermediate Similarity |
NPD6651 |
Approved |
0.7568 |
Intermediate Similarity |
NPD7096 |
Clinical (unspecified phase) |
0.7568 |
Intermediate Similarity |
NPD7819 |
Suspended |
0.7556 |
Intermediate Similarity |
NPD6859 |
Clinical (unspecified phase) |
0.7518 |
Intermediate Similarity |
NPD1243 |
Approved |
0.7518 |
Intermediate Similarity |
NPD2800 |
Approved |
0.7518 |
Intermediate Similarity |
NPD230 |
Phase 1 |
0.75 |
Intermediate Similarity |
NPD6801 |
Discontinued |
0.7482 |
Intermediate Similarity |
NPD3748 |
Approved |
0.7426 |
Intermediate Similarity |
NPD3764 |
Approved |
0.7413 |
Intermediate Similarity |
NPD2309 |
Approved |
0.7405 |
Intermediate Similarity |
NPD1547 |
Clinical (unspecified phase) |
0.7397 |
Intermediate Similarity |
NPD5403 |
Approved |
0.7394 |
Intermediate Similarity |
NPD7421 |
Clinical (unspecified phase) |
0.7388 |
Intermediate Similarity |
NPD2798 |
Approved |
0.7379 |
Intermediate Similarity |
NPD5401 |
Approved |
0.7372 |
Intermediate Similarity |
NPD520 |
Approved |
0.7361 |
Intermediate Similarity |
NPD643 |
Clinical (unspecified phase) |
0.7357 |
Intermediate Similarity |
NPD2799 |
Discontinued |
0.7355 |
Intermediate Similarity |
NPD7852 |
Clinical (unspecified phase) |
0.7355 |
Intermediate Similarity |
NPD1237 |
Approved |
0.7351 |
Intermediate Similarity |
NPD7768 |
Phase 2 |
0.7299 |
Intermediate Similarity |
NPD2313 |
Discontinued |
0.7285 |
Intermediate Similarity |
NPD3817 |
Phase 2 |
0.7279 |
Intermediate Similarity |
NPD6832 |
Phase 2 |
0.7279 |
Intermediate Similarity |
NPD920 |
Approved |
0.7273 |
Intermediate Similarity |
NPD2654 |
Approved |
0.7273 |
Intermediate Similarity |
NPD422 |
Phase 1 |
0.7265 |
Intermediate Similarity |
NPD2934 |
Approved |
0.7265 |
Intermediate Similarity |
NPD2933 |
Approved |
0.7261 |
Intermediate Similarity |
NPD3818 |
Discontinued |
0.726 |
Intermediate Similarity |
NPD642 |
Clinical (unspecified phase) |
0.7244 |
Intermediate Similarity |
NPD6167 |
Clinical (unspecified phase) |
0.7244 |
Intermediate Similarity |
NPD6166 |
Phase 2 |
0.7244 |
Intermediate Similarity |
NPD6168 |
Clinical (unspecified phase) |
0.7231 |
Intermediate Similarity |
NPD1548 |
Phase 1 |
0.7226 |
Intermediate Similarity |
NPD6232 |
Discontinued |
0.7218 |
Intermediate Similarity |
NPD3972 |
Approved |
0.7203 |
Intermediate Similarity |
NPD2859 |
Approved |
0.7203 |
Intermediate Similarity |
NPD2860 |
Approved |
0.7197 |
Intermediate Similarity |
NPD7473 |
Discontinued |
0.7161 |
Intermediate Similarity |
NPD6959 |
Discontinued |
0.7143 |
Intermediate Similarity |
NPD2533 |
Approved |
0.7143 |
Intermediate Similarity |
NPD2534 |
Approved |
0.7143 |
Intermediate Similarity |
NPD2532 |
Approved |
0.7125 |
Intermediate Similarity |
NPD5953 |
Discontinued |
0.7124 |
Intermediate Similarity |
NPD4868 |
Clinical (unspecified phase) |
0.7107 |
Intermediate Similarity |
NPD7804 |
Clinical (unspecified phase) |
0.7107 |
Intermediate Similarity |
NPD7054 |
Approved |
0.7107 |
Intermediate Similarity |
NPD7286 |
Phase 2 |
0.7103 |
Intermediate Similarity |
NPD1196 |
Approved |
0.7075 |
Intermediate Similarity |
NPD1543 |
Discontinued |
0.7063 |
Intermediate Similarity |
NPD4750 |
Phase 3 |
0.7063 |
Intermediate Similarity |
NPD7074 |
Phase 3 |
0.7063 |
Intermediate Similarity |
NPD7472 |
Approved |
0.7059 |
Intermediate Similarity |
NPD5402 |
Approved |
0.705 |
Intermediate Similarity |
NPD3268 |
Approved |
0.705 |
Intermediate Similarity |
NPD411 |
Approved |
0.7034 |
Intermediate Similarity |
NPD1202 |
Approved |
0.7034 |
Intermediate Similarity |
NPD1195 |
Approved |
0.7025 |
Intermediate Similarity |
NPD3020 |
Approved |
0.7021 |
Intermediate Similarity |
NPD447 |
Suspended |
0.7019 |
Intermediate Similarity |
NPD6797 |
Phase 2 |
0.7015 |
Intermediate Similarity |
NPD1610 |
Phase 2 |
0.7007 |
Intermediate Similarity |
NPD3300 |
Phase 2 |
0.7 |
Intermediate Similarity |
NPD6020 |
Phase 2 |
0.6993 |
Remote Similarity |
NPD4308 |
Phase 3 |
0.6993 |
Remote Similarity |
NPD1465 |
Phase 2 |
0.6987 |
Remote Similarity |
NPD5494 |
Approved |
0.6986 |
Remote Similarity |
NPD4628 |
Phase 3 |
0.6985 |
Remote Similarity |
NPD3225 |
Approved |
0.6977 |
Remote Similarity |
NPD1241 |
Discontinued |
0.6975 |
Remote Similarity |
NPD7251 |
Discontinued |
0.697 |
Remote Similarity |
NPD1759 |
Phase 1 |
0.6963 |
Remote Similarity |
NPD1481 |
Phase 2 |
0.6954 |
Remote Similarity |
NPD3226 |
Approved |
0.6944 |
Remote Similarity |
NPD6099 |
Approved |
0.6944 |
Remote Similarity |
NPD6100 |
Approved |
0.6934 |
Remote Similarity |
NPD2797 |
Approved |
0.6933 |
Remote Similarity |
NPD4419 |
Clinical (unspecified phase) |
0.6933 |
Remote Similarity |
NPD7808 |
Phase 3 |
0.6933 |
Remote Similarity |
NPD6980 |
Clinical (unspecified phase) |
0.6933 |
Remote Similarity |
NPD4338 |
Clinical (unspecified phase) |
0.6929 |
Remote Similarity |
NPD1296 |
Phase 2 |
0.6923 |
Remote Similarity |
NPD9258 |
Approved |
0.6923 |
Remote Similarity |
NPD919 |
Approved |
0.6923 |
Remote Similarity |
NPD9256 |
Approved |
0.6913 |
Remote Similarity |
NPD7422 |
Clinical (unspecified phase) |
0.6901 |
Remote Similarity |
NPD1933 |
Approved |
0.6901 |
Remote Similarity |
NPD1899 |
Clinical (unspecified phase) |
0.6897 |
Remote Similarity |
NPD2346 |
Discontinued |
0.6894 |
Remote Similarity |
NPD1758 |
Phase 1 |
0.6889 |
Remote Similarity |
NPD1535 |
Discovery |
0.6884 |
Remote Similarity |
NPD1019 |
Discontinued |
0.6871 |
Remote Similarity |
NPD6559 |
Discontinued |
0.6866 |
Remote Similarity |
NPD2932 |
Approved |
0.6866 |
Remote Similarity |
NPD3019 |
Approved |
0.6861 |
Remote Similarity |
NPD1876 |
Approved |
0.6855 |
Remote Similarity |
NPD3926 |
Phase 2 |
0.6839 |
Remote Similarity |
NPD2296 |
Approved |
0.6839 |
Remote Similarity |
NPD4288 |
Approved |
0.6838 |
Remote Similarity |
NPD1608 |
Approved |
0.6835 |
Remote Similarity |
NPD9494 |
Approved |
0.6835 |
Remote Similarity |
NPD1247 |
Approved |
0.6824 |
Remote Similarity |
NPD6190 |
Approved |
0.6812 |
Remote Similarity |
NPD3266 |
Approved |
0.6812 |
Remote Similarity |
NPD3267 |
Approved |
0.6786 |
Remote Similarity |
NPD4908 |
Phase 1 |
0.6786 |
Remote Similarity |
NPD1529 |
Clinical (unspecified phase) |
0.6783 |
Remote Similarity |
NPD111 |
Approved |
0.6781 |
Remote Similarity |
NPD1471 |
Phase 3 |
0.6759 |
Remote Similarity |
NPD3299 |
Clinical (unspecified phase) |
0.6759 |
Remote Similarity |
NPD7033 |
Discontinued |
0.6757 |
Remote Similarity |
NPD6398 |
Clinical (unspecified phase) |
0.6757 |
Remote Similarity |
NPD3400 |
Discontinued |
0.6748 |
Remote Similarity |
NPD1729 |
Discontinued |
0.6742 |
Remote Similarity |
NPD256 |
Approved |
0.6742 |
Remote Similarity |
NPD255 |
Approved |
0.6732 |
Remote Similarity |
NPD7458 |
Discontinued |
0.672 |
Remote Similarity |
NPD1931 |
Clinical (unspecified phase) |
0.672 |
Remote Similarity |
NPD1929 |
Approved |
0.672 |
Remote Similarity |
NPD1930 |
Approved |
0.6719 |
Remote Similarity |
NPD6831 |
Clinical (unspecified phase) |
0.6714 |
Remote Similarity |
NPD1530 |
Clinical (unspecified phase) |
0.6713 |
Remote Similarity |
NPD4307 |
Phase 2 |
0.6711 |
Remote Similarity |
NPD2354 |
Approved |
0.6707 |
Remote Similarity |
NPD7993 |
Clinical (unspecified phase) |
0.6694 |
Remote Similarity |
NPD1432 |
Clinical (unspecified phase) |
0.6692 |
Remote Similarity |
NPD9568 |
Approved |
0.669 |
Remote Similarity |
NPD9279 |
Approved |
0.669 |
Remote Similarity |
NPD4907 |
Clinical (unspecified phase) |
0.6687 |
Remote Similarity |
NPD5844 |
Phase 1 |
0.6686 |
Remote Similarity |
NPD4287 |
Approved |
0.6667 |
Remote Similarity |
NPD3021 |
Approved |
0.6667 |
Remote Similarity |
NPD9089 |
Approved |
0.6667 |
Remote Similarity |
NPD1755 |
Approved |
0.6667 |
Remote Similarity |
NPD4379 |
Clinical (unspecified phase) |
0.6667 |
Remote Similarity |
NPD3022 |
Approved |
0.6644 |
Remote Similarity |
NPD7003 |
Approved |
0.6639 |
Remote Similarity |
NPD844 |
Approved |
0.6639
|
Remote Similarity |
NPD1809 |
Phase 2 |